SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-184757
Filing Date
2023-07-10
Accepted
2023-07-10 17:13:05
Documents
57
Period of Report
2023-07-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d440197d8k.htm   iXBRL 8-K 26585
2 EX-99.1 d440197dex991.htm EX-99.1 40782
3 EX-99.2 d440197dex992.htm EX-99.2 38816
7 GRAPHIC g440197ex99_2s10g1.jpg GRAPHIC 94644
8 GRAPHIC g440197ex99_2s11g1.jpg GRAPHIC 100327
9 GRAPHIC g440197ex99_2s12g1.jpg GRAPHIC 75556
10 GRAPHIC g440197ex99_2s13g1.jpg GRAPHIC 111772
11 GRAPHIC g440197ex99_2s14g1.jpg GRAPHIC 67798
12 GRAPHIC g440197ex99_2s15g1.jpg GRAPHIC 52791
13 GRAPHIC g440197ex99_2s16g1.jpg GRAPHIC 88359
14 GRAPHIC g440197ex99_2s17g1.jpg GRAPHIC 67062
15 GRAPHIC g440197ex99_2s18g1.jpg GRAPHIC 79752
16 GRAPHIC g440197ex99_2s19g1.jpg GRAPHIC 76373
17 GRAPHIC g440197ex99_2s1g1.jpg GRAPHIC 58064
18 GRAPHIC g440197ex99_2s20g1.jpg GRAPHIC 54585
19 GRAPHIC g440197ex99_2s21g1.jpg GRAPHIC 107091
20 GRAPHIC g440197ex99_2s22g1.jpg GRAPHIC 80000
21 GRAPHIC g440197ex99_2s23g1.jpg GRAPHIC 80761
22 GRAPHIC g440197ex99_2s24g1.jpg GRAPHIC 96331
23 GRAPHIC g440197ex99_2s25g1.jpg GRAPHIC 95381
24 GRAPHIC g440197ex99_2s26g1.jpg GRAPHIC 75995
25 GRAPHIC g440197ex99_2s27g1.jpg GRAPHIC 84929
26 GRAPHIC g440197ex99_2s28g1.jpg GRAPHIC 93384
27 GRAPHIC g440197ex99_2s29g1.jpg GRAPHIC 51987
28 GRAPHIC g440197ex99_2s2g1.jpg GRAPHIC 216174
29 GRAPHIC g440197ex99_2s30g1.jpg GRAPHIC 70297
30 GRAPHIC g440197ex99_2s31g1.jpg GRAPHIC 84626
31 GRAPHIC g440197ex99_2s32g1.jpg GRAPHIC 69489
32 GRAPHIC g440197ex99_2s33g1.jpg GRAPHIC 89390
33 GRAPHIC g440197ex99_2s34g1.jpg GRAPHIC 114951
34 GRAPHIC g440197ex99_2s35g1.jpg GRAPHIC 48003
35 GRAPHIC g440197ex99_2s36g1.jpg GRAPHIC 68999
36 GRAPHIC g440197ex99_2s37g1.jpg GRAPHIC 81159
37 GRAPHIC g440197ex99_2s38g1.jpg GRAPHIC 71172
38 GRAPHIC g440197ex99_2s39g1.jpg GRAPHIC 29095
39 GRAPHIC g440197ex99_2s3g1.jpg GRAPHIC 48143
40 GRAPHIC g440197ex99_2s40g1.jpg GRAPHIC 72505
41 GRAPHIC g440197ex99_2s41g1.jpg GRAPHIC 28365
42 GRAPHIC g440197ex99_2s4g1.jpg GRAPHIC 140623
43 GRAPHIC g440197ex99_2s5g1.jpg GRAPHIC 79981
44 GRAPHIC g440197ex99_2s6g1.jpg GRAPHIC 58913
45 GRAPHIC g440197ex99_2s7g1.jpg GRAPHIC 61531
46 GRAPHIC g440197ex99_2s8g1.jpg GRAPHIC 55898
47 GRAPHIC g440197ex99_2s9g1.jpg GRAPHIC 117039
48 GRAPHIC g440197g0710095151746.jpg GRAPHIC 2225
49 GRAPHIC g440197g0710105212846.jpg GRAPHIC 1905
  Complete submission text file 0001193125-23-184757.txt   4810362

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20230710.xsd EX-101.SCH 2889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20230710_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20230710_pre.xml EX-101.PRE 11287
51 EXTRACTED XBRL INSTANCE DOCUMENT d440197d8k_htm.xml XML 3396
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 231080547
SIC: 8071 Services-Medical Laboratories